Clinical Trial

Safety and Efficacy of Intravenous Administration of SHED-CM for ALS

Study acronym: SCA202401
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study evaluates the safety and efficacy of Stem Cell from Human Exfoliated Deciduous teeth Conditioned Media (SHED-CM) in patients with Amyotrophic Lateral Sclerosis (ALS), using the Japanese version of the revised ALS Functional Rating Scale (ALSFRS-R) as an indicator.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-17.
Status change: Recruiting → Active, Not Recruiting 2025-09-08
Trial Details
NCT Number NCT06889857
Lead Sponsor Hitonowa Medical
Collaborators: U-Factor Co.,Ltd.
Conditions Amyotrophic Lateral Sclerosis
Enrollment 10 participants
Start Date 2024-04-05
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-15